High glycemic variability is associated with a reduced T cell cytokine response to influenza A virus
Marcus Z. W. Tong(The University of Queensland), Kirsty R. Short(The University of Queensland), Ellesandra C. Noye(The University of Queensland), Corey Smith(QIMR Berghofer Medical Research Institute), Soi Cheng Law(Translational Research Institute), Emma J. Grant(La Trobe University), Jean‐Baptiste Julla(Centre National de la Recherche Scientifique), Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Jean‐Pierre Riveline(Inserm), Katharina Ronacher(South African Medical Research Council), Fawaz Alzaïd(Centre National de la Recherche Scientifique), Louise C. Rowntree(Peter Doherty Institute), Marco Goeijenbier(Erasmus MC), Carolien E. van de Sandt(The University of Melbourne), Helen L. Barrett(The University of Queensland), Linda A. Gallo(Translational Research Institute), Stéphanie Gras(La Trobe University), Emily S. Dorey(The University of Queensland), Katherine Kedzierska(Infectious Disease Research Institute), Keng Yih Chew(Australian Research Council), Katina D. Hulme(The University of Queensland)
Cited by 3
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage
|Nature Immunology|2016|365
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
|Cell|2021|308
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
|Proceedings of the National Academy of Sciences|2013|287
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
|Frontiers in Cellular and Infection Microbiology|2018|282